| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/29/1997 | CN1141652A Process for producing proteins |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141342A Gene participating in mechanism of secretion of esterase |
| 01/29/1997 | CN1141339A Expression and secretion of hereologous proteins by yarrowia lipolytica transformants |
| 01/28/1997 | US5597946 Method for introduction of disease and pest resistance into plants and novel genes incorporated into plants which code therefor |
| 01/28/1997 | US5597945 Plants genetically enhanced for disease resistance |
| 01/28/1997 | US5597911 Mycobacterial nucleic acid hybridization probes and methods of use |
| 01/28/1997 | US5597908 Anti-apolipoprotein |
| 01/28/1997 | US5597901 Homogeneous human interleukin 2 |
| 01/28/1997 | US5597900 Crystalline interleukin-4 |
| 01/28/1997 | US5597899 Tumor necrosis factor muteins |
| 01/28/1997 | US5597898 NF-κB activation regulatory protein, IκB-β |
| 01/28/1997 | US5597896 Retrovirus human immunodeficiency virus type 2(HIV2), capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
| 01/28/1997 | US5597895 Inhibiting the expression of hiv virus |
| 01/28/1997 | US5597894 Multi-tyrosinated somatostatin analogs |
| 01/28/1997 | US5597893 Preparation of stable insulin analog crystals |
| 01/28/1997 | US5597804 N-sulfonylarginine keto-amide compounds |
| 01/28/1997 | US5597802 In combination with an osmolyte and a stabilizer in a buffered solution; enhances animal growth |
| 01/28/1997 | US5597801 Bactericides, fungicides |
| 01/28/1997 | US5597799 Recombinant agents affecting thrombosis |
| 01/28/1997 | US5597796 Transdermal insulin |
| 01/28/1997 | US5597726 Monoclonal antibodies reactive with a human atheroma associated antigen |
| 01/28/1997 | US5597725 Cadherin-specific antibodies and hybridoma cell lines |
| 01/28/1997 | US5597719 Polypeptide complex, antitumor agent |
| 01/28/1997 | US5597718 Genetically engineering cotton plants for altered fiber |
| 01/28/1997 | US5597711 Factor VIII binding domain of von Willebrand factor |
| 01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| 01/28/1997 | US5597708 Cloning of a malarial gene |
| 01/28/1997 | US5597707 Diagnosis and treatment of lung, breast, colon, and ovarian cancer, recognition of cell membrane protein |
| 01/28/1997 | US5597705 DNA encoding thyroid hormone receptor compositions and methods |
| 01/28/1997 | US5597698 Corn plants |
| 01/28/1997 | US5597693 Hormone response element compositions and assay |
| 01/28/1997 | US5597691 Enzyme inhibitors |
| 01/28/1997 | US5597607 Process for preparing fractionated soybean proteins and foods using the same |
| 01/28/1997 | US5597578 TGF-β protein compositions for inhibition of cell proliferation |
| 01/28/1997 | US5597572 Method of producing Neisseria meningitidis B vaccine, and vaccine produced by method |
| 01/28/1997 | US5597571 Eimeria antigenic composition which elicits antibodies against avian coccidiosis |
| 01/28/1997 | US5597570 Protein recognized by antibodies raised against native P28 of schistosoma mansoni |
| 01/28/1997 | US5597569 Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica |
| 01/28/1997 | CA1338878C 14-beta-gal mammalian lectins |
| 01/26/1997 | CA2182032A1 Peptide recognizable by antibodies recognizing hepatitis c virus c33 antigen |
| 01/23/1997 | WO1997002491A1 Process for detecting specific antibodies acting against hpv proteins |
| 01/23/1997 | WO1997002421A1 Pumping device |
| 01/23/1997 | WO1997002362A1 Nucleic acid encoding a signal mediator protein that induces cellular morphological alterations |
| 01/23/1997 | WO1997002355A1 Recombinant mva virus, and the use thereof |
| 01/23/1997 | WO1997002354A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1 |
| 01/23/1997 | WO1997002353A1 Tissue-specific promoter |
| 01/23/1997 | WO1997002352A1 Use of translationally altered rna to confer resistance to maize dwarf mosaic virus and other monocotyledonous plant viruses |
| 01/23/1997 | WO1997002348A1 Immunogenic detoxified mutant of cholera toxins |
| 01/23/1997 | WO1997002347A1 A human map kinase homolog |
| 01/23/1997 | WO1997002346A2 Novel human chromosome 16 genes, compositions, methods of making and using same |
| 01/23/1997 | WO1997002345A1 Tnf modulation |
| 01/23/1997 | WO1997002344A2 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 01/23/1997 | WO1997002343A1 Expression of ocean fish antifreeze peptide in a food grade organism and its application in food products |
| 01/23/1997 | WO1997002342A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 01/23/1997 | WO1997002286A1 Novel antibiotic peptides |
| 01/23/1997 | WO1997002283A1 Helicobacter antigens |
| 01/23/1997 | WO1997002282A1 Photoreactive peptide derivatives |
| 01/23/1997 | WO1997002280A1 Breast specific genes and proteins |
| 01/23/1997 | WO1997002277A2 Method for producing synthetic n-linked glycoconjugates |
| 01/23/1997 | WO1997002051A2 Cascade polymer complexes |
| 01/23/1997 | WO1997002048A1 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
| 01/23/1997 | WO1997002045A1 Therapeutic agents and autoimmune diseases |
| 01/23/1997 | WO1997002043A1 Prevention of a disease having the characteristics of diabetes |
| 01/23/1997 | WO1997002024A1 Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis |
| 01/23/1997 | WO1997002016A1 Preparations and methods for the treatment of t cell mediated diseases |
| 01/23/1997 | WO1997002004A2 Methods for treating diabetes |
| 01/23/1997 | WO1997001959A1 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits |
| 01/23/1997 | WO1997000063A3 Urocortin peptides |
| 01/23/1997 | WO1996041877A3 Malarial pre-erythrocytic stage polypeptide molecules |
| 01/23/1997 | WO1996040945A3 Nucleic acid respiratory syncytial virus vaccines |
| 01/23/1997 | WO1996040944A3 Fused soluble mhc heterodimer:peptide complexes and their uses |
| 01/23/1997 | WO1996040939A3 Expression of functional vertebrate phospholipases in yeast |
| 01/23/1997 | WO1996040918A3 Novel cd40l mutein |
| 01/23/1997 | WO1996040915A3 Novel ctla4/cd28 ligands and uses therefor |
| 01/23/1997 | WO1996040777A3 Synthetic peptides and pharmaceutical compositions comprising them |
| 01/23/1997 | WO1996038558A3 A human purinergic p2u receptor |
| 01/23/1997 | WO1996025947A3 Induction of e-selectin for targetting therapeutic agents |
| 01/23/1997 | DE19628895A1 Bioactive metal RNA polypeptide |
| 01/23/1997 | DE19526752A1 Recombinant papilloma-like virus particles with deletions in L1 or L2 proteins |
| 01/23/1997 | DE19526174A1 Mittel gegen Tumorwachstum Agents against tumor growth |
| 01/23/1997 | CA2226011A1 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
| 01/23/1997 | CA2225959A1 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 01/23/1997 | CA2225824A1 Breast specific genes and proteins |
| 01/23/1997 | CA2225666A1 Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis |
| 01/23/1997 | CA2225636A1 Photoreactive peptide derivatives |
| 01/23/1997 | CA2225454A1 Methods for treating diabetes |
| 01/23/1997 | CA2224940A1 Interaction of p53 with transcription factor dp-1 |
| 01/23/1997 | CA2223825A1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 01/23/1997 | CA2222722A1 Novel human chromosome 16 genes, compositions, methods of making and using same |
| 01/23/1997 | CA2222371A1 Nucleic acid encoding a signal mediator protein that induces cellular morphological alterations |
| 01/23/1997 | CA2198729A1 A novel human map kinase homolog |
| 01/22/1997 | EP0754755A2 Recombinant autologous Epstein-Barr viral fusion proteins, test kits containing them and methods for the detection of Epstein-Barr virus specific antibodies |
| 01/22/1997 | EP0754754A1 Fk506-binding protein gene |
| 01/22/1997 | EP0754704A2 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 01/22/1997 | EP0754703A1 Peptide sequence that forms mucin sugar chain and technique for modifying protein to be linked with mucin sugar chain |
| 01/22/1997 | EP0754464A2 Methods of treating neuropeptide Y-associated conditions |
| 01/22/1997 | EP0754463A2 Stabilized aqueous liquid preparation of blood coagulation factor XIII |
| 01/22/1997 | EP0754241A1 Hibridization-ligation assays for the detection of specific nucleic acid sequences |
| 01/22/1997 | EP0754237A1 An adenovirus supervector system |